Bulk supplies for pivotal trials in the UK: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. Find more information on https://www.clientpharma.com/what-we-do/project-management/.
We profoundly understand and recognize the numerous risks associated with global drug procurement. We also appreciate the many complexities associated with worldwide storage and distribution of clinical trial supplies. Our team knows the importance of an efficient, robust supply chain — audited & approved — that promotes excellence, security and accountability. We provide batch traceability, supporting documentation (i.e. Certificates of Analysis (CofAs), Batch Release Certificates (BRCs), GMP Statements, stability data, Fit-for-Use (FFU) Statements, Certificates of Conformance (CofCs), Certificates of Origin (CofOs), etc.) and temperature monitoring data – delivering product pedigree and authenticity.
Our open and collaborative approach is tailored to you and your patients’ needs for every study. With dedicated points-of-contact and direct access to senior management, you are always in connection with us. Through regular business review meetings and custom KPIs, we never lose sight of what’s important to you, your team and your program. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch.
ClientPharma is proud to be the new sponsor of the Stretton Starlings netball team, continuing our goal to support equality in sports. As a result, we wish to showcase the team’s smart new match uniforms for the upcoming season, which sets a new precedent as an innovative way forward with the team wearing t-shirts rather than the ‘status quo’ netball dresses. After forming the team six months ago, the Starlings have just completed their first season collectively in a competitive netball league for the first time, emphasizing that age is no barrier with a range from 14 to 47 years old. The team has high expectations for the upcoming season and wishes to inspire, grow, develop, and celebrate local talent in welcoming ladies of all ages and abilities to come and join the team! Stretton Starlings are eager, driven and determined to commence the second season of the Leagues4you Burton-Upon-Trent Netball League, starting from the 9th of January 2023. Read extra details at https://www.clientpharma.com/.
ClientPharma (CP), a global clinical trial supply company, specializing in the procurement of commercial drug for clinical research, announced today it has formed a strategic partnership with TrialCard, a full-service life sciences commercialization partner. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”
Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.